Pronovost: Surveillance Bias Threatens Quality Payment Fairness
2. Costs and benefits of proposed measures should include rational prioritization of which measures to mandate. "Policymakers could require a formal post hoc review evaluating the risks, benefits and harms of the outcome measures after implementation."
3. Performance measures could link a process of care with adverse outcomes when defining incidence of preventable harm. "When standardized surveillance is too costly or risky, processes of care among those sustaining the outcome could be examined. For example, what percentage of patients who develop a DVT (outcome) received appropriate risk assessment and prophylaxis (process)?"
Pronovost this month was named director of the newly established Armstrong Institute for Patient Safety and Quality at Johns Hopkins. He was simultaneously named Johns Hopkins Medicine’s senior vice president for patient safety and quality.
Cheryl Clark is senior quality editor and California correspondent for HealthLeaders Media. She is a member of the Association of Health Care Journalists.
- CVS Ramps Up Retail Clinics with Provider Affiliations
- Medical Errors Third Leading Cause of Death, Senators Told
- 4 Tectonic Shifts Shaking Up Healthcare
- As States Regulate Provider Competition, Common Threads Emerge
- Chronic Disease Care Costs Get Bipartisan Attention
- CareFirst Announces PCMH Program Results
- Mayo Tops U.S. News Best Hospitals Rankings
- Hospitals Seeking to Understand PPACA Impact Turn to Data
- Telemedicine Providers Welcome AMA Guidelines
- Recruiting Retired Clinicians